Related Experiment Video
Updated: May 31, 2025

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
Published on: June 2, 2019
The small molecule peroxiredoxin mimetics restore growth factor signalings and reverse vascular remodeling
Dong Hoon Kang1, Jiran Kim1, Jiyoung Lee1
1Department of Life Science, Ewha Womans University, Seoul, 03760, Republic of Korea.
Abstract:
Epidithio-diketopiperazine (ETP) compound is the family of natural fungal metabolites that are known to exert diverse biological effects, such as immunosuppression and anti-cancer activity, in higher animals. However, an enzyme-like catalytic activity or function of the ETP derivatives has not been reported. Here, we report the generation of novel thiol peroxidase mimetics that possess peroxide-reducing activity through strategic derivatization of the core ETP ring structure. The ETP derivatives with small side chains are the bona fide 2-Cys peroxiredoxin (PRX) mimetics that catalyze the H2O2-reducing reaction specifically coupled to the thioredoxin/thioredoxin reductase system. In contrast, the ETP derivatives with linear chains or a heterocyclic group show H2O2-reducing activity in coupling with both thioredoxin and glutathione systems. Moreover, the ETP derivatives with bulky heterocyclic groups almost lose catalytic activity. The 2-Cys PRX mimetics regulate intracellular H2O2 levels, thereby restoring the receptor Tyr kinase signaling and cellular functions disrupted by the absence of 2-Cys PRX in vascular cells. In a rodent model, the 2-Cys PRX mimetics reverse vascular occlusion in the injured carotid arteries by inhibiting smooth muscle hyperplasia and promoting reendothelialization. Thus, this study reveals a novel chemical platform for complementing defective 2-Cys PRX enzymes in biological systems.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Antihypertensive Drugs: Vasodilators
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
TGF - β Signaling Pathway
Mitogens and the Cell Cycle

